4//SEC Filing
Michaelson Jennifer 4
Accession 0001193125-25-321122
CIK 0001789972other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 5:00 PM ET
Size
6.8 KB
Accession
0001193125-25-321122
Insider Transaction Report
Form 4
Michaelson Jennifer
Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-12-12$12.38/sh−2,148$26,592→ 137,873 total - Sale
Common Stock
2025-12-15$11.90/sh−995$11,841→ 136,878 total
Footnotes (3)
- [F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
- [F2]Includes 2,017 shares of common stock that the Reporting Person purchased pursuant to the Issuer's 2021 Employee Stock Purchase Plan for the purchase period of January 1, 2025 through June 30, 2025 that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F3]Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025.
Documents
Issuer
Cullinan Therapeutics, Inc.
CIK 0001789972
Entity typeother
Related Parties
1- filerCIK 0001838061
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 5:00 PM ET
- Size
- 6.8 KB